{"id":11501,"date":"2022-07-01T20:40:29","date_gmt":"2022-07-01T20:40:29","guid":{"rendered":"https:\/\/www.cancerresearch.org\/event\/la-covid-19-y-la-investigacion-en-inmunoterapia-aportes-de-la-ciencia-de-primera-linea-de-la-inmunooncologia-para-informar-sobre-estrategias-de-tratamiento-y-prevencion-de-la-covid-19\/"},"modified":"2022-07-01T20:40:29","modified_gmt":"2022-07-01T20:40:29","slug":"la-covid-19-y-la-investigacion-en-inmunoterapia-aportes-de-la-ciencia-de-primera-linea-de-la-inmunooncologia-para-informar-sobre-estrategias-de-tratamiento-y-prevencion-de-la-covid-19","status":"publish","type":"cri_events","link":"https:\/\/www.cancerresearch.org\/es\/events\/la-covid-19-y-la-investigacion-en-inmunoterapia-aportes-de-la-ciencia-de-primera-linea-de-la-inmunooncologia-para-informar-sobre-estrategias-de-tratamiento-y-prevencion-de-la-covid-19","title":{"rendered":"La COVID-19 y la investigaci\u00f3n en inmunoterapia: aportes de la ciencia de primera l\u00ednea de la inmunooncolog\u00eda para informar sobre estrategias de tratamiento y prevenci\u00f3n de la COVID-19"},"content":{"rendered":"<p><iframe loading=\"lazy\" allow=\"accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen=\"\" frameborder=\"0\" height=\"315\" src=\"https:\/\/www.youtube.com\/embed\/GEftbzCOyS0\" width=\"560\"><\/iframe><\/p>\n<p><a class=\"btnArrow\" href=\"\/future\">Apoye la investigaci\u00f3n de la inmunoterapia oncol\u00f3gica<\/a><\/p>\n<p>El CRI presenta una conversaci\u00f3n en vivo con los expertos en inmunoterapia del CRI, los doctores Carl H. June, Miriam Merad y E. John Wherry, con la moderaci\u00f3n de Matthew Herper, de STAT, en la que se analizan algunas de las formas en que la investigaci\u00f3n sobre el sistema inmunitario y su respuesta al c\u00e1ncer y enfermedades infecciosas no solo ha dado lugar a nuevos tratamientos que salvan vidas de pacientes con c\u00e1ncer, sino que tambi\u00e9n contribuye con los esfuerzos mundiales para tratar a los pacientes con COVID-19 y prevenir futuros brotes.&nbsp;<\/p>\n<h2>Participantes<\/h2>\n<p><strong>Dr. CARL H. JUNE<\/strong><br \/>\nDirector del Centro de Inmunoterapias Celulares<br \/>\nEscuela de Medicina Perelman &#8211; Universidad de Pensilvania<br \/>\nMiembro del Consejo Asesor Cient\u00edfico del CRI<br \/>\nTwitter: <a href=\"https:\/\/twitter.com\/carlhjune\" target=\"_blank\" rel=\"noopener\">@carlhjune<\/a><\/p>\n<p><strong>Dra. MIRIAM MERAD, Ph. D.<\/strong><br \/>\nDirectora del Instituto de Inmunolog\u00eda de Precisi\u00f3n<br \/>\nEscuela de Medicina Icahn en Mount Sinai<br \/>\nTwitter: <a href=\"https:\/\/twitter.com\/MiriamMerad\" target=\"_blank\" rel=\"noopener\">@miriammerad<\/a><\/p>\n<p><strong>E. JOHN WHERRY, Ph. D.<\/strong><br \/>\nDirector del Instituto de Inmunolog\u00eda<br \/>\nUniversidad de Pensilvania&nbsp;<br \/>\nDirector Adjunto del Consejo Asesor Cient\u00edfico del CRI<br \/>\nTwitter: <a href=\"https:\/\/twitter.com\/ejohnwherry\" target=\"_blank\" rel=\"noopener\">@ejohnwherry<\/a><\/p>\n<p><em>Moderador:<\/em><\/p>\n<p><strong>MATTHEW HERPER<\/strong><br \/>\nRedactor Senior en Medicina<br \/>\n<em>STAT&nbsp;<\/em><br \/>\nTwitter: <a href=\"https:\/\/twitter.com\/matthewherper\" target=\"_blank\" rel=\"noopener\">@matthewherper<\/a><\/p>\n<h2>Sobre los expertos<\/h2>\n<p><strong><a href=\"https:\/\/www.cancerresearch.org\/scientific-advisory-council\/carl-h-june\"><img decoding=\"async\" alt=\"Carl H. June, MD\" src=\"\/getmedia\/be110327-5f55-4ec4-9806-82c7263cb676\/june_269.jpg.aspx;.xml?width=250&amp;height=250\" style=\"width: 250px; height: 250px; float: left; margin: 10px;\" \/><\/a>El Dr. Carl H. June<\/strong> es profesor de la c\u00e1tedra de Inmunoterapia Richard W. Vague del Departamento de Patolog\u00eda y Medicina de Laboratorio, director del Centro de Inmunoterapia Celular de la Escuela de Medicina Perelman, y director del Instituto Parker de Inmunoterapia contra el C\u00e1ncer de la Universidad de Pensilvania. Su laboratorio de investigaci\u00f3n estudia varios mecanismos de activaci\u00f3n de linfocitos relacionados con la tolerancia inmunitaria y la inmunoterapia adoptiva para el c\u00e1ncer y la infecci\u00f3n cr\u00f3nica. Ha publicado m\u00e1s de 350 manuscritos y recibi\u00f3 numerosos premios y honores, incluida la elecci\u00f3n para el Instituto de Medicina en 2012, la Academia de Artes y Ciencias de EE. UU. en 2014, y la Academia Nacional de Ciencias en 2020. En 2012 recibi\u00f3 los premios <a href=\"https:\/\/www.cancerresearch.org\/william-b-coley-award\">William B. Coley<\/a> del CRI, Richard V. Smalley Memorial de la Sociedad para la Inmunoterapia del C\u00e1ncer, <a href=\"https:\/\/www.cancerresearch.org\/lloyd-j-old-award\">AACR-CRI Lloyd J. Old en Inmunolog\u00eda del c\u00e1ncer<\/a>, y Philadelphia. En 2014 recibi\u00f3 los premios Taubman a la Excelencia en Investigaci\u00f3n M\u00e9dica Aplicada, Paul Ehrlich y Ludwig Darmstaedter, Novartis de Inmunolog\u00eda, Karl Landsteiner Memorial, Debrecen, y un premio a la trayectoria de la Sociedad de Leucemia y Linfoma.<\/p>\n<p><strong><img decoding=\"async\" alt=\"Miriam Merad, MD, PhD\" src=\"\/CRI\/media\/Events\/merad-269sq.jpg\" style=\"float: left; margin: 10px;\" \/>La Dra. Miriam Merad, Ph. D.<\/strong>, es catedr\u00e1tica de Inmunolog\u00eda del C\u00e1ncer en Mount Sinai y directora del Instituto de Inmunolog\u00eda de Precisi\u00f3n en la Escuela de Medicina Icahn de Mount Sinai, Nueva York. Tambi\u00e9n codirige el programa de inmunolog\u00eda del c\u00e1ncer en The Tisch Cancer Institute de Mount Sinai y es directora del Human Immune Monitoring Center de Mount Sinai. Su laboratorio hizo descubrimientos cruciales para comprender los mecanismos que controlan el desarrollo y la identidad funcional de las c\u00e9lulas dendr\u00edticas y los macr\u00f3fagos residentes en tejidos durante la homeostasis, y para examinar c\u00f3mo cambian estos mecanismos en el c\u00e1ncer y las enfermedades inflamatorias.&nbsp;Autora de m\u00e1s de 170 art\u00edculos y rese\u00f1as principales en publicaciones destacadas, recibe generosos fondos de los Institutos Nacionales de Salud (NIH) para su investigaci\u00f3n sobre la inmunidad innata y su contribuci\u00f3n a las enfermedades humanas; tambi\u00e9n participa en varias asociaciones de los NIH. En 2018, la Dra. Merad recibi\u00f3 el prestigioso premio <a href=\"https:\/\/www.cancerresearch.org\/william-b-coley-award\">William B. Coley a la Investigaci\u00f3n Destacada en Inmunolog\u00eda B\u00e1sica y Tumoral<\/a>. Fue elegida para integrar la Sociedad Americana de Investigaciones Cl\u00ednicas, y da conferencias sobre su trabajo en todo el mundo.<\/p>\n<p><strong><a href=\"https:\/\/www.cancerresearch.org\/scientific-advisory-council\/e-john-wherry\"><img decoding=\"async\" alt=\"E. John Wherry, PhD\" src=\"\/getmedia\/a686e4ae-0f4e-4d2a-9495-fa57f33ab4f4\/wherry_269.jpg.aspx;.xml?width=250&amp;height=250\" style=\"width: 250px; height: 250px; float: left; margin: 10px;\" \/><\/a><\/strong><strong>E. John Wherry, Ph. D.<\/strong>,&nbsp;, Barbara and Richard Schiffrin President&rsquo;s Distinguished Professor, es catedr\u00e1tico del Departamento de Farmacolog\u00eda de Sistemas y Terap\u00e9utica Aplicada en la Facultad de Medicina de Perelman y director del Instituto de Inmunolog\u00eda de la Universidad de Pensilvania. La principal \u00e1rea de experiencia del Dr. Wherry es el agotamiento de c\u00e9lulas T que puede obstaculizar las respuestas inmunitarias antitumorales. Public\u00f3 m\u00e1s de 200 art\u00edculos, muchos de los cuales ayudaron a ampliar la comprensi\u00f3n del impacto de los cambios en la expresi\u00f3n de este agotamiento, dando lugar a estrategias para mejorar la eficacia de las inmunoterapias dirigidas a las c\u00e9lulas T. En reconocimiento a sus logros, el Dr. Wherry recibi\u00f3 los premios Distinguished Alumni de la Universidad Thomas Jefferson, Stand Up To Cancer Phillip A. Sharp, y <a href=\"https:\/\/www.cancerresearch.org\/frederick-w-alt-award\">Frederick W. Alt 2016 por nuevos hallazgos en inmunolog\u00eda<\/a> del CRI. Adem\u00e1s, es miembro del Clinical Leadership Committee del CRI.<\/p>\n<h2>Sobre el moderador<\/h2>\n<p><strong><img decoding=\"async\" alt=\"Matthew Herper\" src=\"\/getmedia\/e3e397c9-1040-4987-9728-955532102776\/herper_269.jpg.aspx;.xml?width=250&amp;height=250\" style=\"width: 250px; height: 250px; float: left; margin: 10px;\" \/>Matthew Herper <\/strong>es redactor senior en medicina de <em>STAT<\/em>, una compa\u00f1\u00eda de medios dedicada a buscar y contar historias convincentes sobre salud, medicina y descubrimientos cient\u00edficos. Durante dos d\u00e9cadas ha cubierto la innovaci\u00f3n m\u00e9dica, tanto sus oportunidades como sus riesgos, y ha escrito cr\u00f3nicas sobre el desarrollo de la medicina gen\u00e9tica y el costo creciente de los nuevos medicamentos. En su carrera present\u00f3 a importantes personas, desde Martin Shkreli hasta Bill Gates. De 2000 a 2018 ha escrito sobre ciencia y medicina para Forbes, unos 17 art\u00edculos de portada, y ha hecho de la Conferencia de Salud de Forbes uno de los eventos m\u00e1s importantes de la industria.<\/p>\n<p>Siga el evento en las redes sociales y comparta sus impresiones con el hashtag <a href=\"https:\/\/twitter.com\/hashtag\/CIM20?f=live\" target=\"_blank\" rel=\"noopener\">#CIM20<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Aportes de la ciencia de primera l\u00ednea de la inmunooncolog\u00eda para informar sobre estrategias de tratamiento y prevenci\u00f3n de la COVID-19. Evento transmitido en directo con los doctores Carl H. June, Miriam Merad y E. John Wherry, moderado por Matthew Herper, <em>STAT<\/em><\/p>\n","protected":false},"featured_media":1125,"template":"","events_categories":[],"resource_cancer_types":[],"resource_patient_age":[],"resource_cancer_stage":[],"resource_treatment_type":[],"resource_treatment_status":[],"class_list":["post-11501","cri_events","type-cri_events","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>COVID-19 and Cancer Immunotherapy Research Live Stream Event<\/title>\n<meta name=\"description\" content=\"How science from the frontlines of immuno-oncology is helping inform strategies to treat and prevent COVID-19. Live stream event with Drs. Carl H. June, Miriam Merad, and E. John Wherry; moderated by Matthew Herper, STAT\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/events\/la-covid-19-y-la-investigacion-en-inmunoterapia-aportes-de-la-ciencia-de-primera-linea-de-la-inmunooncologia-para-informar-sobre-estrategias-de-tratamiento-y-prevencion-de-la-covid-19\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"COVID-19 and Cancer Immunotherapy Research Live Stream Event\" \/>\n<meta property=\"og:description\" content=\"How science from the frontlines of immuno-oncology is helping inform strategies to treat and prevent COVID-19. Live stream event with Drs. Carl H. June, Miriam Merad, and E. John Wherry; moderated by Matthew Herper, STAT\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/events\/la-covid-19-y-la-investigacion-en-inmunoterapia-aportes-de-la-ciencia-de-primera-linea-de-la-inmunooncologia-para-informar-sobre-estrategias-de-tratamiento-y-prevencion-de-la-covid-19\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/0e8b00d1-e3e9-4f2c-8406-293eae2112e8.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"COVID-19 and Cancer Immunotherapy Research Live Stream Event\" \/>\n<meta name=\"twitter:description\" content=\"How science from the frontlines of immuno-oncology is helping inform strategies to treat and prevent COVID-19. Live stream event with Drs. Carl H. June, Miriam Merad, and E. John Wherry; moderated by Matthew Herper, STAT\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/0e8b00d1-e3e9-4f2c-8406-293eae2112e8.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/la-covid-19-y-la-investigacion-en-inmunoterapia-aportes-de-la-ciencia-de-primera-linea-de-la-inmunooncologia-para-informar-sobre-estrategias-de-tratamiento-y-prevencion-de-la-covid-19\",\"url\":\"https:\/\/www.cancerresearch.org\/events\/la-covid-19-y-la-investigacion-en-inmunoterapia-aportes-de-la-ciencia-de-primera-linea-de-la-inmunooncologia-para-informar-sobre-estrategias-de-tratamiento-y-prevencion-de-la-covid-19\",\"name\":\"COVID-19 and Cancer Immunotherapy Research Live Stream Event\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/la-covid-19-y-la-investigacion-en-inmunoterapia-aportes-de-la-ciencia-de-primera-linea-de-la-inmunooncologia-para-informar-sobre-estrategias-de-tratamiento-y-prevencion-de-la-covid-19#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/la-covid-19-y-la-investigacion-en-inmunoterapia-aportes-de-la-ciencia-de-primera-linea-de-la-inmunooncologia-para-informar-sobre-estrategias-de-tratamiento-y-prevencion-de-la-covid-19#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/7c61c878-d1a5-42d3-92d0-8a11d1c068fd.gif\",\"datePublished\":\"2022-07-01T20:40:29+00:00\",\"description\":\"How science from the frontlines of immuno-oncology is helping inform strategies to treat and prevent COVID-19. Live stream event with Drs. Carl H. June, Miriam Merad, and E. John Wherry; moderated by Matthew Herper, STAT\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/la-covid-19-y-la-investigacion-en-inmunoterapia-aportes-de-la-ciencia-de-primera-linea-de-la-inmunooncologia-para-informar-sobre-estrategias-de-tratamiento-y-prevencion-de-la-covid-19#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/events\/la-covid-19-y-la-investigacion-en-inmunoterapia-aportes-de-la-ciencia-de-primera-linea-de-la-inmunooncologia-para-informar-sobre-estrategias-de-tratamiento-y-prevencion-de-la-covid-19\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/la-covid-19-y-la-investigacion-en-inmunoterapia-aportes-de-la-ciencia-de-primera-linea-de-la-inmunooncologia-para-informar-sobre-estrategias-de-tratamiento-y-prevencion-de-la-covid-19#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/7c61c878-d1a5-42d3-92d0-8a11d1c068fd.gif\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/7c61c878-d1a5-42d3-92d0-8a11d1c068fd.gif\",\"width\":700,\"height\":500},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/la-covid-19-y-la-investigacion-en-inmunoterapia-aportes-de-la-ciencia-de-primera-linea-de-la-inmunooncologia-para-informar-sobre-estrategias-de-tratamiento-y-prevencion-de-la-covid-19#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Event\",\"item\":\"https:\/\/www.cancerresearch.org\/events\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"La COVID-19 y la investigaci\u00f3n en inmunoterapia: aportes de la ciencia de primera l\u00ednea de la inmunooncolog\u00eda para informar sobre estrategias de tratamiento y prevenci\u00f3n de la COVID-19\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"COVID-19 and Cancer Immunotherapy Research Live Stream Event","description":"How science from the frontlines of immuno-oncology is helping inform strategies to treat and prevent COVID-19. Live stream event with Drs. Carl H. June, Miriam Merad, and E. John Wherry; moderated by Matthew Herper, STAT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/events\/la-covid-19-y-la-investigacion-en-inmunoterapia-aportes-de-la-ciencia-de-primera-linea-de-la-inmunooncologia-para-informar-sobre-estrategias-de-tratamiento-y-prevencion-de-la-covid-19","og_locale":"es_ES","og_type":"article","og_title":"COVID-19 and Cancer Immunotherapy Research Live Stream Event","og_description":"How science from the frontlines of immuno-oncology is helping inform strategies to treat and prevent COVID-19. Live stream event with Drs. Carl H. June, Miriam Merad, and E. John Wherry; moderated by Matthew Herper, STAT","og_url":"https:\/\/www.cancerresearch.org\/events\/la-covid-19-y-la-investigacion-en-inmunoterapia-aportes-de-la-ciencia-de-primera-linea-de-la-inmunooncologia-para-informar-sobre-estrategias-de-tratamiento-y-prevencion-de-la-covid-19","og_site_name":"Cancer Research Institute","og_image":[{"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/0e8b00d1-e3e9-4f2c-8406-293eae2112e8.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_title":"COVID-19 and Cancer Immunotherapy Research Live Stream Event","twitter_description":"How science from the frontlines of immuno-oncology is helping inform strategies to treat and prevent COVID-19. Live stream event with Drs. Carl H. June, Miriam Merad, and E. John Wherry; moderated by Matthew Herper, STAT","twitter_image":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/0e8b00d1-e3e9-4f2c-8406-293eae2112e8.jpg","twitter_misc":{"Tiempo de lectura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/events\/la-covid-19-y-la-investigacion-en-inmunoterapia-aportes-de-la-ciencia-de-primera-linea-de-la-inmunooncologia-para-informar-sobre-estrategias-de-tratamiento-y-prevencion-de-la-covid-19","url":"https:\/\/www.cancerresearch.org\/events\/la-covid-19-y-la-investigacion-en-inmunoterapia-aportes-de-la-ciencia-de-primera-linea-de-la-inmunooncologia-para-informar-sobre-estrategias-de-tratamiento-y-prevencion-de-la-covid-19","name":"COVID-19 and Cancer Immunotherapy Research Live Stream Event","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/events\/la-covid-19-y-la-investigacion-en-inmunoterapia-aportes-de-la-ciencia-de-primera-linea-de-la-inmunooncologia-para-informar-sobre-estrategias-de-tratamiento-y-prevencion-de-la-covid-19#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/events\/la-covid-19-y-la-investigacion-en-inmunoterapia-aportes-de-la-ciencia-de-primera-linea-de-la-inmunooncologia-para-informar-sobre-estrategias-de-tratamiento-y-prevencion-de-la-covid-19#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/7c61c878-d1a5-42d3-92d0-8a11d1c068fd.gif","datePublished":"2022-07-01T20:40:29+00:00","description":"How science from the frontlines of immuno-oncology is helping inform strategies to treat and prevent COVID-19. Live stream event with Drs. Carl H. June, Miriam Merad, and E. John Wherry; moderated by Matthew Herper, STAT","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/events\/la-covid-19-y-la-investigacion-en-inmunoterapia-aportes-de-la-ciencia-de-primera-linea-de-la-inmunooncologia-para-informar-sobre-estrategias-de-tratamiento-y-prevencion-de-la-covid-19#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/events\/la-covid-19-y-la-investigacion-en-inmunoterapia-aportes-de-la-ciencia-de-primera-linea-de-la-inmunooncologia-para-informar-sobre-estrategias-de-tratamiento-y-prevencion-de-la-covid-19"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/events\/la-covid-19-y-la-investigacion-en-inmunoterapia-aportes-de-la-ciencia-de-primera-linea-de-la-inmunooncologia-para-informar-sobre-estrategias-de-tratamiento-y-prevencion-de-la-covid-19#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/7c61c878-d1a5-42d3-92d0-8a11d1c068fd.gif","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/7c61c878-d1a5-42d3-92d0-8a11d1c068fd.gif","width":700,"height":500},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/events\/la-covid-19-y-la-investigacion-en-inmunoterapia-aportes-de-la-ciencia-de-primera-linea-de-la-inmunooncologia-para-informar-sobre-estrategias-de-tratamiento-y-prevencion-de-la-covid-19#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Event","item":"https:\/\/www.cancerresearch.org\/events"},{"@type":"ListItem","position":3,"name":"La COVID-19 y la investigaci\u00f3n en inmunoterapia: aportes de la ciencia de primera l\u00ednea de la inmunooncolog\u00eda para informar sobre estrategias de tratamiento y prevenci\u00f3n de la COVID-19"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events\/11501","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_events"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/1125"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=11501"}],"wp:term":[{"taxonomy":"events_categories","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/events_categories?post=11501"},{"taxonomy":"resource_cancer_types","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_types?post=11501"},{"taxonomy":"resource_patient_age","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_patient_age?post=11501"},{"taxonomy":"resource_cancer_stage","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_stage?post=11501"},{"taxonomy":"resource_treatment_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_type?post=11501"},{"taxonomy":"resource_treatment_status","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_status?post=11501"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}